Related Experiment Video

Updated: Aug 24, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

[Assessment of surgical treatment in patients with severe depressed left ventricular function]

Andrzej Durałek1, Przemysław Szmagała, Michał Krejca

  • 1I Klinika Kardiochirurgii Sl. AM w Katowicach.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|June 5, 2004
PubMed

Insights

This study found that cardioprotective techniques did not improve surgical outcomes. Key risk factors for cardiac surgery include advanced age, low ejection fraction, and poor coronary artery condition.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Risk Assessment

Background:

  • Perioperative risk stratification is crucial for cardiac surgery outcomes.
  • Cardioprotective techniques are often employed to mitigate surgical risks.
  • Existing risk scales may not fully capture all relevant patient factors.

Purpose of the Study:

  • To analyze perioperative risk factors in cardiac surgery, focusing on cardioprotective techniques.
  • To compare the effectiveness of standard risk scales (Cleveland, Canadian) against a novel scale incorporating coronary artery classification.
  • To identify key predictors of surgical outcomes in patients with severely depressed left ventricular function.

Main Methods:

  • Retrospective analysis of perioperative data.
  • Comparison of standard risk assessment tools (Cleveland, Canadian) with a modified scale including the Graham, Chambers, Davies classification.
  • Regression modeling to determine the predictive value of risk scales (Area Under the ROC Curve).

Main Results:

  • Cardioprotective techniques showed no significant impact on clinical results.
  • Independent predictors of adverse outcomes included age >75 years, ejection fraction <20%, and poor distal coronary artery status.
  • The modified risk scale, incorporating coronary artery classification, improved predictive accuracy for mortality, complications, and length of stay by 3-4%.

Conclusions:

  • Age, ejection fraction, and distal coronary artery condition are critical factors influencing cardiac surgery outcomes.
  • Standard risk scales have moderate predictive value, but incorporating detailed coronary anatomy enhances accuracy.
  • Further refinement of risk assessment tools is warranted for improved patient management in cardiac surgery.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...